Statement Of Cash Flows [Abstract]

ChemoMetec - Filing #1398596

Concept	2021-07-01 to 2022-06-30	As at 2022-06-30	As at 2021-07-01	2020-07-01 to 2021-06-30	As at 2021-06-30	As at 2020-07-01
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Interest paid, classified as operating activities	1,518 DKK	—	—	918,000 DKK	—	—
Interest received, classified as operating activities	9,000 DKK	—	—	88,000 DKK	—	—
Income taxes paid (refund), classified as operating activities	27,634 DKK	—	—	16,569 DKK	—	—
Cash flows from (used in) operating activities	176,860 DKK	—	—	107,901 DKK	—	—
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities	39,101 DKK	—	—	11,249 DKK	—	—
Purchase of intangible assets, classified as investing activities	16,815 DKK	—	—	13,373 DKK	—	—
Cash flows from (used in) investing activities	56,046 DKK	—	—	24,683 DKK	—	—
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities	433,000 DKK	—	—	168,000 DKK	—	—
Payments of lease liabilities, classified as financing activities	1,729 DKK	—	—	854,000 DKK	—	—
Dividends paid, classified as financing activities	69,610 DKK	—	—	26,104 DKK	—	—
Other inflows (outflows) of cash, classified as financing activities	1,895 DKK	—	—	—	—	—
Cash flows from (used in) financing activities	69,012 DKK	—	—	26,037 DKK	—	—
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	51,802 DKK	—	—	57,181 DKK	—	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	7,114 DKK	—	—	4,013 DKK	—	—
Cash and cash equivalents	—	209,025 DKK	150,109 DKK	—	150,109 DKK	96,941 DKK